Non Burkitt
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Fludarabine, Cyclophosphamide, Doxorubicin and Rituximab for the Treatment of Post-transplant Lymphoproliferative Disease (PTLD) (NCT01088724) | A.O. Ospedale Papa Giovanni XXIII | 2002-02-01 |
Track Non Burkitt automatically
Every clearance here is in the API, with alerts when new ones post.